Friday 12th April 2019
Do we need a new way to assess Raynaud’s Phenomenon in clinical trials?
To understand the efficacy of treatment in clinical trials, participants are normally given structured diaries as a way of recording their own observations. Almost 30 years on from these measures being developed, there are questions about whether they are still fit for purpose in today’s landscape